Panbela Therapeutics, Inc. (PBLA) Tops Q1 EPS by 132c

Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q1 EPS of ($2.28), $1.32 better than the analyst estimate of ($3.60).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook